![](/img/cover-not-exists.png)
PCV114 DABIGATRAN ETEXILATE IS COST-SAVING FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS FOLLOWING MAJOR ORTHOPAEDIC SURGERY IN THE NETHERLANDS
C Boersma, BS Kappelhoff, MJ PostmaVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74641-6
File:
PDF, 80 KB
english, 2009